BNGO
Bionano Genomics, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$1.73
−0.57%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.45
- Revenue estimate
- $8.4M
Latest reported
- Last report date
- Aug 10, 2026
- EPS actual
- -$0.64
- EPS estimate
- -$0.67
- Revenue actual
- $8.2M
- Revenue estimate
- $7.6M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +29.8%
- Revenue beats (12Q)
- 7
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 10, 2026 | -$0.67 | -$0.64 | Beat 4.48% | $8.2M |
| May 13, 2026 | -$0.81 | -$0.76 | Beat 6.17% | $6.7M |
| Mar 23, 2026 | -$0.81 | -$0.03 | Beat 96.30% | $8.0M |
| Nov 13, 2025 | -$1.81 | -$1.59 | Beat 12.15% | $7.4M |
| Aug 14, 2025 | -$2.69 | -$1.99 | Beat 26.02% | $6.7M |
| May 14, 2025 | -$3.49 | -$1.15 | Beat 67.05% | $6.5M |
| Mar 31, 2025 | -$6.00 | -$57 | Miss -858.17% | $8.2M |
| Nov 14, 2024 | -$0.21 | -$19 | Miss -9023.81% | $6.1M |
| Mar 5, 2024 | -$0.87 | -$57 | Miss -6508.05% | $10.7M |
| Nov 8, 2023 | -$45 | -$89 | Miss -97.33% | $9.3M |
| Mar 9, 2023 | -$54 | -$78 | Miss -44.44% | $8.2M |
| Nov 3, 2022 | -$72 | -$66 | Beat 8.34% | $7.2M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026